Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39035
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oreja-Guevara, C. | - |
dc.contributor.author | Benedict, R. H. | - |
dc.contributor.author | Comi, G. | - |
dc.contributor.author | Cutter, G. | - |
dc.contributor.author | Kister, I. | - |
dc.contributor.author | Siva, A. | - |
dc.contributor.author | Wiendl, H. | - |
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Wuerfel, J. | - |
dc.contributor.author | El Azzouzi, B. | - |
dc.contributor.author | Buffels, R. | - |
dc.contributor.author | Dirks, P. | - |
dc.contributor.author | Kuenzel, T. | - |
dc.contributor.author | Vermersch, P. | - |
dc.date.accessioned | 2022-12-15T07:33:12Z | - |
dc.date.available | 2022-12-15T07:33:12Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2022-12-09T12:55:50Z | - |
dc.identifier.citation | Multiple Sclerosis Journal, 28 (S3) , p. 327 -329 | - |
dc.identifier.uri | http://hdl.handle.net/1942/39035 | - |
dc.description.sponsorship | F. Hoffmann-La Roche Ltd; Articulate Science, UK | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | Efficacy and safety of ocrelizumab is maintained in patients with RRMS with suboptimal response to prior disease-modifying therapies: 4-year NEDA data from CASTING-LIBERTO | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | OCT 26-28, 2022 | - |
local.bibliographicCitation.conferencename | 38th Congress of the | - |
local.bibliographicCitation.conferencename | European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis | - |
local.bibliographicCitation.conferenceplace | Amsterdam, NETHERLANDS | - |
dc.identifier.epage | 329 | - |
dc.identifier.issue | S3 | - |
dc.identifier.spage | 327 | - |
dc.identifier.volume | 28 | - |
local.format.pages | 3 | - |
local.bibliographicCitation.jcat | M | - |
local.publisher.place | 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | 000866540801286 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. | - |
local.description.affiliation | [Benedict, R. H.] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA. | - |
local.description.affiliation | [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. | - |
local.description.affiliation | [Cutter, G.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA. | - |
local.description.affiliation | [Kister, I.] NYU, Langone Med Ctr, Multiple Sclerosis Comprehens Care Ctr, New York, NY USA. | - |
local.description.affiliation | [Siva, A.] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey. | - |
local.description.affiliation | [Wiendl, H.] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany. | - |
local.description.affiliation | [Van Wijmeersch, B.] Hasselt Univ, Univ MS Ctr, Hasselt, Belgium. | - |
local.description.affiliation | [Wuerfel, J.] Univ Basel, Dept Biomed Engn, Med Image Anal Ctr MIAC AG, Basel, Switzerland. | - |
local.description.affiliation | [Wuerfel, J.] Univ Magdeburg, Dept Neuroradiol, Magdeburg, Germany. | - |
local.description.affiliation | [El Azzouzi, B.; Buffels, R.; Dirks, P.; Kuenzel, T.] F Hoffmann La Roche Ltd, Basel, Switzerland. | - |
local.description.affiliation | [Vermersch, P.] Univ Lille, Inserm LilNCog U1172, CHU Lille, FHU Precise, Lille, France. | - |
local.uhasselt.international | yes | - |
item.fulltext | With Fulltext | - |
item.contributor | Oreja-Guevara, C. | - |
item.contributor | Benedict, R. H. | - |
item.contributor | Comi, G. | - |
item.contributor | Cutter, G. | - |
item.contributor | Kister, I. | - |
item.contributor | Siva, A. | - |
item.contributor | Wiendl, H. | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Wuerfel, J. | - |
item.contributor | El Azzouzi, B. | - |
item.contributor | Buffels, R. | - |
item.contributor | Dirks, P. | - |
item.contributor | Kuenzel, T. | - |
item.contributor | Vermersch, P. | - |
item.accessRights | Open Access | - |
item.fullcitation | Oreja-Guevara, C.; Benedict, R. H.; Comi, G.; Cutter, G.; Kister, I.; Siva, A.; Wiendl, H.; VAN WIJMEERSCH, Bart; Wuerfel, J.; El Azzouzi, B.; Buffels, R.; Dirks, P.; Kuenzel, T. & Vermersch, P. (2022) Efficacy and safety of ocrelizumab is maintained in patients with RRMS with suboptimal response to prior disease-modifying therapies: 4-year NEDA data from CASTING-LIBERTO. In: Multiple Sclerosis Journal, 28 (S3) , p. 327 -329. | - |
crisitem.journal.issn | 1352-4585 | - |
crisitem.journal.eissn | 1477-0970 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Efficacy and safety of ocrelizumab is maintained in patients with RRMS with.pdf | Published version | 7.08 MB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.